Clinical trials of WR-2721 prior to alkylating agent chemotherapy and radiotherapy

Pharmacol Ther. 1988;39(1-3):3-7. doi: 10.1016/0163-7258(88)90032-0.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Alkylating Agents / adverse effects
  • Alkylating Agents / antagonists & inhibitors*
  • Amifostine / therapeutic use*
  • Cisplatin / antagonists & inhibitors
  • Cyclophosphamide / antagonists & inhibitors
  • Drug Evaluation
  • Humans
  • Neoplasms / drug therapy*
  • Neoplasms / radiotherapy*
  • Organothiophosphorus Compounds / therapeutic use*
  • Radiation Injuries / prevention & control

Substances

  • Alkylating Agents
  • Organothiophosphorus Compounds
  • Cyclophosphamide
  • Amifostine
  • Cisplatin